https://orcid.org/0000-0003-2875-3744
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ivette Maldonado, Manuel Plata, Mauricio Gonzalez, Alfonso Correa, Claudia Nossa, Anna R. Giuliano, Elmar A. Joura, Alex Ferenczy, Brigitte M. Ronnett, Mark H. Stoler, Hao Jin Zhou, Amita Joshi, Rituparna Das, Oliver Bautista, Thomas Group, Alain Luxembourg, Alfred Saah & Ulrike Kirsten Buchwald. (2022) Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
E Karafillakis, P Peretti-Watel, P Verger, T Chantler & HJ Larson. (2022) “We don’t have the same bodies; we don’t react the same way”: mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination in France. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Noelia López, Ignacio Salamanca de la Cueva, Edelmiro Vergés, Eva Suárez Vicent, Almudena Sánchez, Ana Belén López, María Belén Panizo-Santos, María Garcés-Sánchez, Abián Montesdeoca, Antonio José Rivera & Manuel Suárez Cotarelo. (2022) Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study). Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Articles from other publishers (17)
Caroline Dombrowski, Claire Bourgain, Yixuan Ma, Anne Meiwald, Amy Pinsent, Birgit Weynand, Katy M.E. Turner, Susie Huntington, Elisabeth J. Adams, Johannes Bogers, Romaric Croes & Shaira Sahebali. (2023) An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing. European Journal of Cancer Prevention.
Crossref
Crossref
Fabricio Romero García, Johanna Norenhag, Gabriella Edfeldt, Liqin Cheng, Luisa Warchavchik Hugerth, Alexandra A. L. Pennhag, Ina Schuppe-Koistinen, Lars Engstrand, Matts Olovsson & Juan Du. (2023) Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in Sweden. BJC Reports 1:1.
Crossref
Crossref
Mateusz Jankowski, Justyna Grudziąż-Sękowska, Iwona Wrześniewska-Wal, Piotr Tyszko, Kuba Sękowski, Janusz Ostrowski, Mariusz Gujski & Jarosław Pinkas. (2023) National HPV Vaccination Program in Poland—Public Awareness, Sources of Knowledge, and Willingness to Vaccinate Children against HPV. Vaccines 11:8, pages 1371.
Crossref
Crossref
Yuwei Li, Yi-Fan Lin, Xinsheng Wu, Xinyi Zhou, Tian Tian, Zhihui Guo, Leiwen Fu, Luoyao Yang, Zhen Lu, Song Fan, Yong Lu, Wujian Ke & Huachun Zou. (2023) Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study. Frontiers in Immunology 14.
Crossref
Crossref
Yulia Gendler. (2023) Development and Appraisal of a Web-Based Decision Aid for HPV Vaccination for Young Adults and Parents of Children in Israel—A Quasi-Experimental Study. Vaccines 11:6, pages 1038.
Crossref
Crossref
Vahap Eldem, Selim Can Kuralay, Gülperi Özdoğan, Gökçe Has Özçelik, Dilşah Aydın, Gökçe Çakmak, Mürüvvet Özlem Gürler, Selahattin Barış Çay, Yusuf Ulaş Çınar, Fatih Dikmen, Ishak Yusuf, Onur Obut, Özgecan Kayalar, Gözde Ertürk Zararsız, Masoud Edizadeh, Gökmen Zararsız, Eren Akdeniz, Hilal Özgür & Ismihan Merve Tekin. (2023) Comprehensive analysis of circulating viral DNA in maternal plasma at population-scale using low-pass whole-genome sequencing. Genomics 115:2, pages 110556.
Crossref
Crossref
Hristina Lebanova, Svetoslav Stoev, Emilia Naseva, Violeta Getova, Wei Wang, Ugne Sabale & Elina Petrova. (2023) Economic Burden of Cervical Cancer in Bulgaria. International Journal of Environmental Research and Public Health 20:3, pages 2746.
Crossref
Crossref
Ilias Gountas, Andrea Favre-Bulle, Kunal Saxena, Jessica Wilcock, Hannah Collings, Stina Salomonsson, Anastasios Skroumpelos & Ugne Sabale. (2023) Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery. Vaccines 11:2, pages 258.
Crossref
Crossref
Clare Bennett, Deborah Edwards, Sue M Sherman, Peter Baker, Dur-e-Nayab Waheed, Alex Vorsters, Hüsna Sarıca Çevik, Emilie Karafillakis, Gillian Prue & Daniel Kelly. (2022) Which interventions improve HPV vaccination uptake and intention in children, adolescents and young adults? An umbrella review. Sexually Transmitted Infections 98:8, pages 599-607.
Crossref
Crossref
Nadja Taumberger, Elmar A Joura, Marc Arbyn, Maria Kyrgiou, Jalid Sehouli & Murat Gultekin. (2022) Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee. International Journal of Gynecologic Cancer 32:10, pages 1316-1320.
Crossref
Crossref
Philippe Gorphe, Pierre Blanchard, Gabriel C. T. E. Garcia, Marion Classe, Caroline Even, Stéphane Temam & Ingrid Breuskin. (2022) 2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France. BMC Cancer 22:1.
Crossref
Crossref
Violeta Alarcão & Bilyana Zdravkova. (2022) Attitudes and Practices towards HPV Vaccination and Its Social Processes in Europe: An Equity-Focused Scoping Review. Societies 12:5, pages 131.
Crossref
Crossref
Piotr Sypień & Tadeusz M. Zielonka. (2022) Knowledge and Awareness of Polish Parents on Vaccination against Human Papillomavirus. Vaccines 10:7, pages 1156.
Crossref
Crossref
Yiwei Li, Yu Guo & Hong Lin. (2022) Feminized Virus: A Content Analysis of Social Media’s Representation of HPV Vaccine. Social Media + Society 8:3, pages 205630512211042.
Crossref
Crossref
Monika Hampl, Peter Hillemanns & Matthias Jentschke. (2022) Erweiterte Indikation für die HPV-Impfung: Wer kann profitieren?. Geburtshilfe und Frauenheilkunde 82:01, pages 26-30.
Crossref
Crossref
Michael Wojcinski. (2021) 14 Jahre HPV-Impfung: was haben wir erreicht?14 years of HPV vaccination: what has been achieved?. Der Gynäkologe 54:11, pages 801-809.
Crossref
Crossref
Rosa De Vincenzo, Nicola Caporale, Valentina Bertoldo, Caterina Ricci, Maria Teresa Evangelista, Nicolò Bizzarri, Luigi Pedone Anchora, Giovanni Scambia & Giovanni Capelli. (2021) HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study. Vaccines 9:6, pages 643.
Crossref
Crossref